The Chemical Antibody: How the Aptamers Market is Revolutionizing Molecular Recognition and Therapeutics
The global biotechnology sector is witnessing a paradigm shift towards nucleic acid-based recognition molecules that offer unique advantages over traditional antibodies. At the forefront of this revolution is the Aptamers Market, a sector poised for explosive growth as it addresses critical challenges in diagnostics, therapeutics, and drug delivery. Valued at approximately USD 3.27 billion...
0 Comments 0 Shares 191 Views 0 Reviews